Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
30 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/us-fda-approves-tremfya-guselkumab-for-the-treatment-of-pediatric-plaque-psoriasis-and-active-psoriatic-arthritis-marking-a-first-and-only-approval-for-an-il-23-inhibitor-302569442.html
29 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-29/icotrokinra-shows-superiority-to-deucravacitinib-in-first-reported-head-to-head-trials-reinforcing-promise-of-investigational-targeted-oral-peptide-fo
24 Sep 2025
// FDA
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/janssen-vaccines-corp-johnson-johnson-company-713194-07182025
20 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tremfya-guselkumab-achieves-us-approval-for-subcutaneous-induction-in-adults-with-ulcerative-colitis-now-the-first-and-only-il-23-inhibitor-with-a-fully-subcutaneous-regimen-302561993.html
19 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/19/3153234/0/en/TREMFYA-guselkumab-receives-positive-CHMP-opinion-for-subcutaneous-induction-regimen-in-ulcerative-colitis-a-first-for-an-IL-23-inhibitor.html
19 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tecvayli-and-darzalex-faspro-based-induction-treatment-demonstrates-promising-rates-and-depths-of-response-in-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma-302561499.html
Excipients
REF. STANDARDS & IMPURITIES
Inspections and registrations
ABOUT THIS PAGE
Johnson & Johnson is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Nicotine bulk with DMF offered by Johnson & Johnson
Find a price of Naloxone Hydrochloride bulk offered by Johnson & Johnson
Find a price of Sodium Hyaluronate bulk offered by Johnson & Johnson